Connect Biopharma Holdings Limited

NASDAQ:CNTB

Biotechnology

Healthcare
$0.80 -4.09%

-$0.09 today

Market cap
$50.52M
Beta
-0.21
P/E (TTM)
-4.0
EPS (TTM)
-$0.50
52W Low $0.91High $3.82

Volume 2.50M

Average 0.30M

CNTB Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

Connect Biopharma Holdings LimitedNASDAQ: CNTB

Deferred Tax Liabilities · Q4 FY2025 · quarter ended Dec 2025

Deferred tax liabilities remains negative

Q4 FY2025 deferred tax liabilities was $0, compared with $0 a year earlier.

Context

  • Deferred tax liabilities amounted to 0.0% of total assets at the end of Q4 FY2025, unchanged from a year earlier.
  • Deferred tax liabilities increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoDec 2024
$0— since
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Deferred Tax Liabilities vs competitors

How CNTB compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred tax liabilities is compared through growth and share of total assets rather than absolute size.
  • Deferred tax liabilities amounts to 0.0% of total assets for CNTB, versus a peer median of 0.0%.
CNTB Competitors
Deferred Tax Liabilities for CNTB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CNTBConnect Biopharma Holdings LimitedDec 2025$0 USD——0.0%
STTKShattuck Labs, Inc.Mar 2026$0 USD——0.0%
OVIDOvid Therapeutics Inc.Mar 2026$0 USD——0.0%
IFRXInflaRx N.V.Mar 2026€0 EUR——0.0%
ARTVArtiva Biotherapeutics, Inc.Mar 2026$0 USD——0.0%
STROSutro Biopharma, Inc.Mar 2026$0 USD——0.0%
IMAImageneBio IncMar 2026$0 USD——0.0%
KLRSKalaris Therapeutics IncMar 2026$0 USD——0.0%
CNTXContext Therapeutics Inc.Mar 2026$0 USD——0.0%
Peer median (excluding CNTB) ———0.0%

Competitors are the stored peer set for CNTB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents267.72M79.01M105.66M78.23M38.35M
Short-term Investments073.41M12.64M15.48M6M
Net Receivables7.41M232K351K1.05M161K
Inventory00000
Other Current Assets0054K419K29K
Total Current Assets275.13M155.78M122.55M96.96M50.93M
Property, Plant & Equipment (Net)9.44M5.38M4.74M4.24M4.46M
Goodwill00000
Intangible Assets3.54M3.17M62K53K45K
Long-term Investments09.44M000
Tax Assets00000
Other Non-current Assets2.95M252K24K33K646K
Total Non-current Assets15.93M18.23M4.82M4.32M5.15M
Total Assets291.05M174.01M127.38M101.28M56.08M
Account Payables12.74M11.94M2.21M342K1.96M
Short-term Debt00000
Tax Payables00000
Deferred Revenue0013.32M164K167K
Other Current Liabilities002.05M3.34M2.91M
Total Current Liabilities17.99M15.62M25.29M8.46M13.61M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)784K652K405K00
Other Non-current Liabilities000632K114K
Total Non-current Liabilities810K897K585K656K482K
Total Liabilities18.8M16.52M25.88M9.12M14.1M
Common Stock10K10K10K10K10K
Retained Earnings(361.75M)(479.84M)(329.73M)(345.36M)(400.84M)
Accumulated OCI(4.03M)(7.63M)(1.01M)(1.67M)(1.19M)
Other Stockholders Equity9.57M16.47M000
Minority Interest00000
Total Equity272.26M157.49M101.5M92.17M41.98M
Total Debt125K431K465K178K690K
Net Debt(267.59M)(78.58M)(105.2M)(78.05M)(37.66M)

Connect Biopharma Holdings Limited

NASDAQ:CNTB

Intrinsic Alpha fair value

Locked

Current Price

$0.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.